JO3056B1 - Propane-1-sulfonic acid { 3-[5-(4-chloro-phenyl)-1h-pyrrolo [2,3-b] pyridine -3-carbonyl]-2,4-difluoro-phenyl} amide composition and uses thereof - Google Patents
Propane-1-sulfonic acid { 3-[5-(4-chloro-phenyl)-1h-pyrrolo [2,3-b] pyridine -3-carbonyl]-2,4-difluoro-phenyl} amide composition and uses thereofInfo
- Publication number
- JO3056B1 JO3056B1 JOP/2010/0105A JOP20100105A JO3056B1 JO 3056 B1 JO3056 B1 JO 3056B1 JO P20100105 A JOP20100105 A JO P20100105A JO 3056 B1 JO3056 B1 JO 3056B1
- Authority
- JO
- Jordan
- Prior art keywords
- phenyl
- pyrrolo
- difluoro
- carbonyl
- pyridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Abstract
Provided are solid dispersions, solid molecular complexes, salts and crystalline polymorphs involving propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16667709P | 2009-04-03 | 2009-04-03 | |
US17605109P | 2009-05-06 | 2009-05-06 | |
EP09175665 | 2009-11-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
JO3056B1 true JO3056B1 (en) | 2017-03-15 |
Family
ID=54978682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JOP/2010/0105A JO3056B1 (en) | 2009-04-03 | 2010-04-01 | Propane-1-sulfonic acid { 3-[5-(4-chloro-phenyl)-1h-pyrrolo [2,3-b] pyridine -3-carbonyl]-2,4-difluoro-phenyl} amide composition and uses thereof |
Country Status (4)
Country | Link |
---|---|
HK (2) | HK1168590A1 (en) |
HR (1) | HRP20151156T1 (en) |
IL (1) | IL251336B (en) |
JO (1) | JO3056B1 (en) |
-
2010
- 2010-04-01 JO JOP/2010/0105A patent/JO3056B1/en active
-
2012
- 2012-07-30 HK HK12107426.5A patent/HK1168590A1/en unknown
-
2015
- 2015-10-30 HR HRP20151156TT patent/HRP20151156T1/en unknown
-
2016
- 2016-05-05 HK HK16105154.3A patent/HK1217195A1/en unknown
-
2017
- 2017-03-22 IL IL251336A patent/IL251336B/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
HRP20151156T1 (en) | 2016-01-01 |
IL251336A0 (en) | 2017-05-29 |
HK1168590A1 (en) | 2013-01-04 |
IL251336B (en) | 2020-04-30 |
HK1217195A1 (en) | 2016-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY172424A (en) | Propane- i-sulfonic acid {3- (4-chloro-phenyl)-1h-pyrrolo [2, 3-b] pyridine-3-carconyl] -2, 4-difluoro-phenyl} -amide compositions and uses thereof | |
PL2013208T3 (en) | Pyridin[3,4-b]pyrazinones | |
PL2595958T3 (en) | Novel processes for the manufacture of propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide | |
ZA201202024B (en) | PROPANE-1-SULFONIC ACID {3-[5-(4-CHLOROPHENYL)-1H-PYRROLO[2,3-b] PYRIDINE-3-CARBONY]-2,4-DIFLUOLOPHENYL}-AMIDE, AS WELL AS USES THEREOF | |
EG25765A (en) | Pyrido [2,3-B] pyrazine derivatives useful as herbicidal compounds | |
EP2387315A4 (en) | IMIDAZO[1,2-a]PYRIDINES AND IMIDAZO[1,2-b]PYRIDAZINES AS MARK INHIBITORS | |
HK1141524A1 (en) | 3-(imidazolyl)-pyrazolo[3,4-b]pyridines 3-()-[34-b] | |
ZA201301313B (en) | Herbicidal isoxazolo[5,4-b]pyridines | |
ZA201005069B (en) | Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives useful as modulator of nicotinic acetylcholine receptors | |
JO3056B1 (en) | Propane-1-sulfonic acid { 3-[5-(4-chloro-phenyl)-1h-pyrrolo [2,3-b] pyridine -3-carbonyl]-2,4-difluoro-phenyl} amide composition and uses thereof | |
PL2040723T3 (en) | Lactic acid bacterium with increased acid tolerance | |
CY1116983T1 (en) | COMPOUNDS OF PROPANO-1-SULFONIC ACID {3- [5- (4-chloro-phenyl) -1H-pyrrolo [2,3-B] pyridine-3-carbonyl] -2,4-difluoro-finelyl} - AMYL} THESE | |
BR122020005420B8 (en) | purified form 1 of the crystalline polymorph of compound i | |
EP2459550A4 (en) | R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial | |
UA108842C2 (en) | SOLID DISPERSION, THE METHOD OF ITS RECEIPT, AND ALSO THE COMPOSITION AND THE MEDICINAL FORM CONTAINED | |
GB0622263D0 (en) | Lactic acid polymers |